<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28697/efficacy-and-safety-of-combination-eribulin-pembrolizumab?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Efficacy and Safety of Combination Eribulin + Pembrolizumab

Name: Efficacy and Safety of Combination Eribulin + Pembrolizumab
Uploaded: 2019-07-02T06:20:41
Duration: 2 min 1 s
Description: Sara Tolaney, MD, Associate Director, Susan F. Smith Center for Womens Cancers, Director Clinical Trials, Breast Oncology, Associate Professor of Medicine, Harvard Medical School elaborates on the efficacy and safety of combination eribulin and pembrolizumab in metastatic breast cancer.

00:02:01

Don

3 years 429 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28697/efficacy-and-safety-of-combination-eribulin-pembrolizumab?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28697/efficacy-and-safety-of-combination-eribulin-pembrolizumab?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28697/efficacy-and-safety-of-combination-eribulin-pembrolizumab?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28697?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190702182041_884a/video_190702182041_884a.jpg?cache=15669160801678829655">Efficacy and Safety of Combination Eribulin + Pembrolizumab</a>

Link (BBCode):

[url=https://oncologytube.com/v/28697?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190702182041_884a/video_190702182041_884a.jpg?cache=15669160801678829655[/img]Efficacy and Safety of Combination Eribulin + Pembrolizumab[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Breast

Description:

Sara Tolaney, MD, Associate Director, Susan F. Smith Center for Womens Cancers, Director Clinical Trials, Breast Oncology, Associate Professor of Medicine, Harvard Medical School elaborates on the efficacy and safety of combination eribulin and pembrolizumab in metastatic breast cancer.